Thera Plus Maximum Strength Feminine Anti-Itch

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Thera Plus Maximum Strength Feminine Anti-Itch
Generic name
BENZOCAINE, RESORCINOL
Manufacturer
FOURSTAR GROUP USA, INC.
Product type
HUMAN OTC DRUG
SPL set ID
0007e3ea-882b-4000-8e70-2bcec2c08613
SPL ID
2f0c45da-c4f2-bd12-e063-6394a90aba99
Version
2
Effective date
2025-02-26
Source export date
2026-11-13
Source partition
12
Source file
https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/df974ce21ba33b4471866e2af5412327fbd4bcd68d14b42d7cfb3aa15d163738/drug-label-0012-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 17:49:43
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. When using this product avoid contact with the eyes. Stop use and ask a doctor if condition worsens, or if symptoms persists for more than 7 days or clear up and occur again within a few days. Do not apply over large areas of the body. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.